Home › Funds › NEA Management Company, LLC › GLUE
NEA Management Company, LLC position in GLUE
MONTE ROSA THERAPEUTICS INC · Health Care
NEA Management Company, LLC reported holding 6,692,298 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$79.8M, representing 5.85% of its reported portfolio and ranking #7 among its reported holdings. NEA Management Company, LLC has disclosed GLUE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How NEA Management Company, LLC's GLUE position evolved
NEA Management Company, LLC first disclosed a stake in GLUE in Q3 2023 at 7,692,298 shares (US$36.8M). The position peaked in Q2 2026 at 7,692,298 shares, worth US$186.2M. Across 13 filings, NEA Management Company, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 6,692,298 shares valued at US$79.8M — a reduction of -1,000,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 7.69M | $36.85M | New |
| Q4 2023 | 7.69M | $43.46M | Hold |
| Q1 2024 | 7.69M | $54.23M | Hold |
| Q2 2024 | 7.69M | $28.77M | Hold |
| Q3 2024 | 7.69M | $40.77M | Hold |
| Q4 2024 | 7.69M | $53.38M | Hold |
| Q1 2025 | 7.69M | $35.69M | Hold |
| Q2 2025 | 7.69M | $34.69M | Hold |
| Q3 2025 | 7.69M | $57.00M | Hold |
| Q4 2025 | 7.69M | $120.62M | Hold |
| Q1 2026 | 7.69M | $126.54M | Hold |
| Q2 2026 | 7.69M | $186.15M | Hold |
| Q3 2026 | 6.69M | $79.84M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GLUE and 13F data
GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in GLUE — the largest reported positions include Vestal Point Capital, LP (US$85.1M), BAKER BROS. ADVISORS LP (US$51.8M), BVF INC/IL (US$51.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GLUE
- Vestal Point Capital, LP 7.13M sh · $85.06M · Q3 2026
- BAKER BROS. ADVISORS LP 4.35M sh · $51.84M · Q3 2026
- BVF INC/IL 4.28M sh · $51.02M · Q3 2026
- TCG Crossover Management, LLC 3.78M sh · $45.11M · Q3 2026
- Versant Venture Management, LLC 3.18M sh · $37.95M · Q3 2026
- MONTANOVA CAPITAL, LLC 2.92M sh · $34.79M · Q3 2026
- BRAIDWELL LP 2.53M sh · $30.14M · Q3 2026
- Aisling Capital Management LP 1.56M sh · $18.56M · Q3 2026
- Opaleye Management Inc. 745.00K sh · $18.03M · Q2 2026
- MPM BioImpact LLC 1.13M sh · $13.42M · Q3 2026
- ADAR1 Capital Management, LLC 1.01M sh · $12.02M · Q3 2026
- Frazier Life Sciences Management, L.P. 1.00M sh · $11.93M · Q3 2026
More on NEA Management Company, LLC
FAQ
How long has NEA Management Company, LLC held GLUE?
NEA Management Company, LLC has disclosed GLUE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is NEA Management Company, LLC's current position in GLUE?
As of Q3 2026, NEA Management Company, LLC holds 6.69M shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $79.84M, representing 5.85% of its reported portfolio and ranking #7.
Has NEA Management Company, LLC been buying or selling GLUE?
In the latest 13F filing (Q3 2026), NEA Management Company, LLC reduced its position in GLUE. The position peaked in Q2 2026 at 7.69M shares.
Which other funds hold GLUE?
Other major institutional holders of GLUE include Vestal Point Capital, LP, BAKER BROS. ADVISORS LP, BVF INC/IL, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.